2019 Novel Coronavirus (COVID-19). (n.d.). American Academy of Pediatrics. Retrieved September 22, 2020, from https://patiented.solutions.aap.org/handout.aspx?gbosid=535624
Fang, L., Karakiulakis, G., & Roth, M. (2020). Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The Lancet Respiratory Medicine, 8(4), e21. https://doi.org/10.1016/s2213-2600(20)30116-8
FDA advises patients on use of NSAIDs for COVID-19. (2020, March 19). U.S. Food and Drug Administration. Retrieved September 22, 2020, from https://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-patients-use-non-steroidal-anti-inflammatory-drugs-nsaids-covid-19
How to safely give ibuprofen. (n.d.). Nemours KidsHealth. Retrieved September 22, 2020, from https://kidshealth.org/en/parents/ibuprofen.html
Moore, N., Carleton, B., Blin, P., Bosco-Levy, P., & Droz, C. (2020). Does ibuprofen worsen COVID-19? Drug Safety, 43(7), 611-614. https://doi.org/10.1007/s40264-020-00953-0
Rinott, E., Kozer, E., Shapira, Y., Bar-Haim, A., & Youngster, I. (2020). Ibuprofen use and clinical outcomes in COVID-19 patients. Clinical Microbiology and Infection, 26(9), 1259.e5-1259.e7. https://doi.org/10.1016/j.cmi.2020.06.003
The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19. (2020, April 19). WHO | World Health Organization. Retrieved September 22, 2020, from https://www.who.int/news-room/commentaries/detail/the-use-of-non-steroidal-anti-inflammatory-drugs-(nsaids)-in-patients-with-covid-19